|
1
|
Lin C, Lin P, Yao H, Liu S, Lin X, He R,
Teng Z, Zuo X, Li Y, Ye J and Zhu G: Modulation of YBX1-mediated
PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to
oxaliplatin in gastric cancer. Cancer Lett. 587:2167122024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mao S, Xie C, Liu Y, Zhao Y, Li M, Gao H,
Xiao Y, Zou Y, Zheng Z, Gao Y, et al: Apurinic/apyrimidinic
endodeoxyribonuclease 1 (APE1) promotes stress granule formation
via YBX1 phosphorylation in ovarian cancer. Cell Mol Life Sci.
81:1132024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Fan JS, Li S, Yang Y, Sun P, Zhu
Q, Wang J, Jiang B, Yang D and Liu M: Structural basis of DNA
binding to human YB-1 cold shock domain regulated by
phosphorylation. Nucleic Acids Res. 48:9361–9371. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen SJ, Zhang J, Zhou T, Rao SS, Li Q,
Xiao LY, Wei ST and Zhang HF: Epigenetically upregulated NSUN2
confers ferroptosis resistance in endometrial cancer via m(5)C
modification of SLC7A11 mRNA. Redox Biol. 69:1029752024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Y, Wei J, Feng L, Li O, Huang L, Zhou
S, Xu Y, An K, Zhang Y, Chen R, et al: Aberrant m5C
hypermethylation mediates intrinsic resistance to gefitinib through
NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
Mol Cancer. 22:812023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J, Ji L, Liang Y, Zheng W, Song X,
Gorshkov K, Sun Q, Lin H, Zheng X, Chen J, et al: CircRNA-SORE
mediates sorafenib resistance in hepatocellular carcinoma by
stabilizing YBX1. Signal Transduct Target Ther. 5:2982020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet
Y, Luo Q, Yang D, Zuo X, Chen N, et al: RNA m(5)C modification
upregulates E2F1 expression in a manner dependent on YBX1 phase
separation and promotes tumor progression in ovarian cancer. Exp
Mol Med. 56:600–615. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song S, He X, Wang J, Song H, Wang Y, Liu
Y, Zhou Z, Yu Z, Miao D and Xue Y: A novel long noncoding RNA,
TMEM92-AS1, promotes gastric cancer progression by binding to YBX1
to mediate CCL5. Mol Oncol. 15:1256–1273. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu T, Xiong M, Hong Q, Pan B, Xu M, Wang
Y, Sun Y, Sun H, Pan Y, Wang S and He B: Hsa_circ_0007990 promotes
breast cancer growth via inhibiting YBX1 protein degradation to
activate E2F1 transcription. Cell Death Dis. 15:1532024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Cao C, Zhou CL, Li X, Miao C,
Shen L, Singla RK and Lu X: Identification of a novel
5-methylcytosine-related signature for prognostic prediction of
kidney renal papillary cell carcinoma and a Putative target for
drug repurposing. Transl Oncol. 36:1017412023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Yin H, Chen Y, Pan C, Hang H, Lu
Y, Ma W, Li X, Gan W, Guo H and Li D: Low expression of PEBP1P2
promotes metastasis of clear cell renal cell carcinoma by
post-transcriptional regulation of PEBP1 and KLF13 mRNA. Exp
Hematol Oncol. 11:872022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gandhi M, Groß M, Holler JM, Coggins SA,
Patil N, Leupold JH, Munschauer M, Schenone M, Hartigan CR,
Allgayer H, et al: The lncRNA lincNMR regulates nucleotide
metabolism via a YBX1-RRM2 axis in cancer. Nat Commun. 11:32142020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lyabin DN, Eliseeva IA and Ovchinnikov LP:
YB-1 protein: Functions and regulation. Wiley Interdiscip Rev RNA.
5:95–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu XM, Ma L and Schekman R: Selective
sorting of microRNAs into exosomes by phase-separated YBX1
condensates. Elife. 10:e719822021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng M, Xie X, Han G, Zhang T, Li Y, Li Y,
Yin R, Wang Q, Zhang T, Wang P, et al: YBX1 is required for
maintaining myeloid leukemia cell survival by regulating BCL2
stability in an m6A-dependent manner. Blood. 138:71–85. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Budkina K, El Hage K, Clément MJ,
Desforges B, Bouhss A, Joshi V, Maucuer A, Hamon L, Ovchinnikov LP,
Lyabin DN and Pastré D: YB-1 unwinds mRNA secondary structures in
vitro and negatively regulates stress granule assembly in HeLa
cells. Nucleic Acids Res. 49:10061–10081. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dheeraj A, Garcia Marques FJ, Tailor D,
Bermudez A, Resendez A, Pandrala M, Grau B, Kumar P, Haley CB,
Honkala A, et al: Inhibition of protein translational machinery in
triple-negative breast cancer as a promising therapeutic strategy.
Cell Rep Med. 5:1015522024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li B, Xing F, Wang J, Wang X, Zhou C, Fan
G, Zhuo Q, Ji S, Yu X, Xu X, et al: YBX1 as a therapeutic target to
suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine
resistance in pancreatic cancer. Cancer Lett. 602:2171972024.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng H, Miao H, Zhang Y, Chen T, Yuan L,
Wan Y, Jiang Y, Zhang L and Cheng W: YBX1 promotes homologous
recombination and resistance to platinum-induced stress in ovarian
cancer by recognizing m5C modification. Cancer Lett.
597:2170642024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tailor D, Resendez A, Garcia-Marques FJ,
Pandrala M, Going CC, Bermudez A, Kumar V, Rafat M, Nambiar DK,
Honkala A, et al: Y box binding protein 1 inhibition as a targeted
therapy for ovarian cancer. Cell Chem Biol. 28:1206–1220.e6. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Didier DK, Schiffenbauer J, Woulfe SL,
Zacheis M and Schwartz BD: Characterization of the cDNA encoding a
protein binding to the major histocompatibility complex class II Y
box. Proc Natl Acad Sci USA. 85:7322–7326. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gai XX, Lipson KE and Prystowsky MB:
Unusual DNA binding characteristics of an in vitro translation
product of the CCAAT binding protein mYB-1. Nucleic Acids Res.
20:601–606. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spitkovsky DD, Royer-Pokora B, Delius H,
Kisseljov F, Jenkins NA, Gilbert DJ, Copeland NG and Royer HD:
Tissue restricted expression and chromosomal localization of the
YB-1 gene encoding a 42 kD nuclear CCAAT binding protein. Nucleic
Acids Res. 20:797–803. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asakuno K, Kohno K, Uchiumi T, Kubo T,
Sato S, Isono M and Kuwano M: Involvement of a DNA binding protein,
MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.
Biochem Biophys Res Commun. 199:1428–1435. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Makino Y, Ohga T, Toh S, Koike K, Okumura
K, Wada M, Kuwano M and Kohno K: Structural and functional analysis
of the human Y-box binding protein (YB-1) gene promoter. Nucleic
Acids Res. 24:1873–1878. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuwano M, Shibata T, Watari K and Ono M:
Oncogenic Y-box binding protein-1 as an effective therapeutic
target in drug-resistant cancer. Cancer Sci. 110:1536–1543. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun X, Gao C, Xu X, Li M, Zhao X, Wang Y,
Wang Y, Zhang S, Yan Z, Liu X and Wu C: FBL promotes cancer cell
resistance to DNA damage and BRCA1 transcription via YBX1. EMBO
Rep. 24:e562302023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bates M, Boland A, McDermott N and
Marignol L: YB-1: The key to personalised prostate cancer
management? Cancer Lett. 490:66–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan
X, Chen RX, Wei WS, Liu Y, Gao CC, et al: 5-methylcytosine promotes
pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell
Biol. 21:978–990. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Wang L, Han X, Yang WL, Zhang M,
Ma HL, Sun BF, Li A, Xia J, Chen J, et al: RNA 5-methylcytosine
facilitates the maternal-to-Zygotic transition by preventing
maternal mRNA. Decay Mol Cell. 75:1188–1202.e11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barbieri I and Kouzarides T: Role of RNA
modifications in cancer. Nat Rev Cancer. 20:303–322. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nombela P, Miguel-López B and Blanco S:
The role of m(6)A, m(5)C and Ψ RNA modifications in cancer: Novel
therapeutic opportunities. Mol Cancer. 20:182021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo G, Pan K, Fang S, Ye L, Tong X, Wang
Z, Xue X and Zhang H: Advances in mRNA 5-methylcytosine
modifications: Detection, effectors, biological functions, and
clinical relevance. Mol Ther Nucleic Acids. 26:575–593. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu
L, Liu J, Li F, Li W and Liu H: RNA modification in cardiovascular
disease: Implications for therapeutic interventions. Signal
Transduct Target Ther. 8:4122023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dai X, Gonzalez G, Li L, Li J, You C, Miao
W, Hu J, Fu L, Zhao Y, Li R, et al: YTHDF2 Binds to
5-Methylcytosine in RNA and modulates the maturation of ribosomal
RNA. Anal Chem. 92:1346–1354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang G, Liu L, Li J, Chen Y, Wang Y,
Zhang Y, Dong Z, Xue W, Sun R and Cui G: NSUN2 stimulates tumor
progression via enhancing TIAM2 mRNA stability in pancreatic
cancer. Cell Death Discov. 9:2192023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu W, Wan F, Xu W, Liu Z, Wang J, Zhang
H, Huang S and Ye D: Positive epigenetic regulation loop between AR
and NSUN2 promotes prostate cancer progression. Clin Transl Med.
12:e10282022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han X, Wang M, Zhao YL, Yang Y and Yang
YG: RNA methylations in human cancers. Semin Cancer Biol.
75:97–115. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L,
Wang Y, Fan R, Wang X and Shi Y: RNA modifications: Importance in
immune cell biology and related diseases. Signal Transduct Target
Ther. 7:3342022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang N, Tang H, Wang X, Wang W and Feng J:
Homocysteine upregulates interleukin-17A expression via
NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys
Res Commun. 493:94–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zou S, Huang Y, Yang Z, Zhang J, Meng M,
Zhang Y, Feng J, Sun R, Li W, Wang W, et al: NSUN2 promotes
colorectal cancer progression by enhancing SKIL mRNA stabilization.
Clin Transl Med. 14:e16212024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu
H, Yin S, Chen Q, Xie X, Ren X, et al: Metabolic recoding of
NSUN2-Mediated m(5)C modification promotes the progression of
colorectal cancer via the NSUN2/YBX1/m(5)C-ENO1 positive feedback
loop. Adv Sci (Weinh). 11:e23098402024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Y, Xue M, Deng X, Nguyen LXT, Ren L,
Han L, Li C, Xue J, Zhao Z, Li W, et al: TET2-mediated mRNA
demethylation regulates leukemia stem cell homing and self-renewal.
Cell Stem Cell. 30:1072–1090.e10. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng S, Hu C, Lin Q, Li T, Li G, Tian Q,
Zhang X, Huang T, Ye Y, He R, et al: Extracellular vesicle-packaged
PIAT from cancer-associated fibroblasts drives neural remodeling by
mediating m5C modification in pancreatic cancer mouse models. Sci
Transl Med. 16:eadi01782024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang L, Zhang J, Su Y, Maimaitiyiming Y,
Yang S, Shen Z, Lin S, Shen S, Zhan G, Wang F, et al: Distinct
roles of m(5)C RNA methyltransferase NSUN2 in major gynecologic
cancers. Front. Oncol. 12:7862662022.PubMed/NCBI
|
|
46
|
Chen Y, Jiang Z, Zhang C, Zhang L, Chen H,
Xiao N, Bai L, Liu H and Wan J: 5-Methylcytosine transferase NSUN2
drives NRF2-mediated ferroptosis resistance in non-small cell lung
cancer. J Biol Chem. 300:1067932024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao W, Chen L, Lin L, Yang M, Li T, Wei H,
Sha C, Xing J, Zhang M, Zhao S, et al: SIAH1 reverses
chemoresistance in epithelial ovarian cancer via ubiquitination of
YBX-1. Oncogenesis. 11:132022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu T, Zhang Q, Yu SK, Nie FQ, Zhang ML,
Wang Q and Lu KH: THOC3 interacts with YBX1 to promote lung
squamous cell carcinoma progression through PFKFB4 mRNA
modification. Cell Death Dis. 14:4752023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yin H, Huang Z, Niu S, Ming L, Jiang H, Gu
L, Huang W, Xie J, He Y and Zhang C: 5-Methylcytosine (m(5)C)
modification in peripheral blood immune cells is a novel
non-invasive biomarker for colorectal cancer diagnosis. Front
Immunol. 13:9679212022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu K, Xu P, Lv J, Ge H, Yan Z, Huang S,
Li B, Xu H, Yang L, Xu Z and Zhang D: Peritoneal high-fat
environment promotes peritoneal metastasis of gastric cancer cells
through activation of NSUN2-mediated ORAI2 m5C modification.
Oncogene. 42:1980–1993. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen Y, Zuo X, Wei Q, Xu J, Liu X, Liu S,
Wang H, Luo Q, Wang Y, Yang Y, et al: Upregulation of LRRC8A by
m(5)C modification-mediated mRNA stability suppresses apoptosis and
facilitates tumorigenesis in cervical cancer. Int J Biol Sci.
19:691–704. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li YJ, Guo Q, Ye MS, Cai G, Xiao WF, Deng
S and Xiao Y: YBX1 promotes type H vessel-dependent bone formation
in an m5C-dependent manner. JCI Insight. 9:e1723452024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu R, Feng S, Li F, Shu G, Wang L, Gao P,
Zhu X, Zhu C, Wang S and Jiang Q: Transcriptional and
post-transcriptional control of autophagy and adipogenesis by YBX1.
Cell Death Dis. 14:292023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Boo SH and Kim YK: The emerging role of
RNA modifications in the regulation of mRNA stability. Exp Mol Med.
52:400–408. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Delaunay S and Frye M: RNA modifications
regulating cell fate in cancer. Nat Cell Biol. 21:552–559. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu Y, Yang D, Liu T, Chen J, Yu J and Yi
P: N6-methyladenosine-mediated gene regulation and therapeutic
implications. Trends Mol Med. 29:454–467. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fazi F and Fatica A: Interplay between N
(6)-Methyladenosine (m(6)A) and non-coding RNAs in cell development
and cancer. Front Cell Dev Biol. 7:1162019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Olazagoitia-Garmendia A, Rojas-Márquez H,
Sebastian-delaCruz M, Agirre-Lizaso A, Ochoa A, Mendoza-Gomez LM,
Perugorria MJ, Bujanda L, Madrigal AH, Santin I and
Castellanos-Rubio A: m(6) a methylated long noncoding RNA LOC339803
regulates intestinal inflammatory response. Adv Sci (Weinh).
11:e23079282024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang R, Xu X, Yang J, Chen W, Zhao J, Wang
M, Zhang Y, Yang Y, Huang W and Zhang H: BPDE exposure promotes
trophoblast cell pyroptosis and induces miscarriage by
up-regulating lnc-HZ14/ZBP1/NLRP3 axis. J Hazard Mater.
455:1315432023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang Q, Wei T, Yan L, Zhu S, Jin W, Bai
Y, Zeng Y, Zhang X, Yin Z, Yang J, et al: Hypoxia-Responsive lncRNA
AC115619 encodes a micropeptide that suppresses m6A modifications
and hepatocellular carcinoma progression. Cancer Res. 83:2496–2512.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zheng H, Zhu M, Li W, Zhou Z and Wan X:
m(5) C and m(6) A modification of long noncoding NKILA accelerates
cholangiocarcinoma progression via the miR-582-3p-YAP1 axis. Liver
Int. 42:1144–1157. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yan J, Liu J, Huang Z, Huang W and Lv J:
FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in
gastric cancer cells. Hum. Cell. 34:1755–1764. 2021.
|
|
63
|
Li H, Lin R, Zhang Y, Zhu Y, Huang S, Lan
J, Lu N, Xie C, He S and Zhang W: N6-methyladenosine-modified
circPLPP4 sustains cisplatin resistance in ovarian cancer cells via
PIK3R1 upregulation. Mol Cancer. 23:52024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zeng K, Peng J, Xing Y, Zhang L, Zeng P,
Li W, Zhang W, Pan Z, Zhou C and Lin J: A positive feedback circuit
driven by m(6)A-modified circular RNA facilitates colorectal cancer
liver metastasis. Mol Cancer. 22:2022023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wu S, Tang W, Liu L, Wei K, Tang Y, Ma J,
Li H and Ao Y: Obesity-induced downregulation of miR-192
exacerbates lipopolysaccharide-induced acute lung injury by
promoting macrophage activation. Cell Mol Biol Lett. 29:362024.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
van den Homberg DAL, van der Kwast R, Quax
PHA and Nossent AY: N-6-Methyladenosine in Vasoactive microRNAs
during Hypoxia; A novel role for METTL4. Int J Mol Sci.
23:10572022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhou L, Jiang J, Huang Z, Jin P, Peng L,
Luo M, Zhang Z, Chen Y, Xie N, Gao W, et al: Hypoxia-induced lncRNA
STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal
cancer progression by preventing m(6)A-mediated degradation of
STEAP3 mRNA. Mol Cancer. 21:1682022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Qi YN, Liu Z, Hong LL, Li P and Ling ZQ:
Methyltransferase-like proteins in cancer biology and potential
therapeutic targeting. J Hematol Oncol. 16:892023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wu Y, Li J, Li C, Lu S, Wei X, Li Y, Xia
W, Qian C, Wang Z, Liu M, et al: Fat mass and obesity-associated
factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis
in an age-dependent manner. J Biol Chem. 299:1047832023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Jin KX, Zuo R, Anastassiadis K, Klungland
A, Marr C and Filipczyk A: N6-methyladenosine (m(6)A) depletion
regulates pluripotency exit by activating signaling pathways in
embryonic stem cells. Proc Natl Acad Sci USA. 118:e21051921182021.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Dou X, Xiao Y, Shen C, Wang K, Wu T, Liu
C, Li Y, Yu X, Liu J, Dai Q, et al: RBFOX2 recognizes
N(6)-methyladenosine to suppress transcription and block myeloid
leukaemia differentiation. Nat Cell Biol. 25:1359–1368. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ma L, Zhou X, Yao S, Zhang X, Mao J, Vona
B, Fan L, Lou S, Li D, Wang L and Pan Y: METTL3-dependent m(6)A
modification of PSEN1 mRNA regulates craniofacial development
through the Wnt/β-catenin signaling pathway. Cell Death Dis.
15:2292024. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li B, Xiong X, Xu J, Peng D, Nie G, Wen N,
Wang Y and Lu J: METTL3-mediated m(6)A modification of lncRNA
TSPAN12 promotes metastasis of hepatocellular carcinoma through
SENP1-depentent deSUMOylation of EIF3I. Oncogene. 43:1050–1062.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ou X, Tan Y, Xie J, Yuan J, Deng X, Shao
R, Song C, Cao X, Xie X, He R, et al: Methylation of GPRC5A
promotes liver metastasis and docetaxel resistance through
activating mTOR signaling pathway in triple negative breast cancer.
Drug Resist Updat. 73:1010632024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q,
Li Y, Ren J, Song H, Xu Y, et al: The m(6)A modification
mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and
facilitates the growth of colorectal cancer via upregulation of
FASN. Mol Cancer. 23:552024. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang Y, Geng X, Li Q, Xu J, Tan Y, Xiao
M, Song J, Liu F, Fang C and Wang H: m6A modification in RNA:
biogenesis, functions and roles in gliomas. J Exp Clin Cancer Res.
39:1922020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
van Tran N, Ernst FGM, Hawley BR, Zorbas
C, Ulryck N, Hackert P, Bohnsack KE, Bohnsack MT, Jaffrey SR,
Graille M and Lafontaine DLJ: The human 18S rRNA m6A
methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids
Res. 47:7719–7733. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhang L, Li Y, Zhou L, Zhou H, Ye L, Ou T,
Hong H, Zheng S, Zhou Z, Wu K, et al: The m6A Reader YTHDF2
promotes bladder cancer progression by suppressing RIG-I-Mediated
immune response. Cancer Res. 83:1834–1850. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ghazi T, Nagiah S and Chuturgoon AA:
Fusaric acid decreases p53 expression by altering promoter
methylation and m6A RNA methylation in human hepatocellular
carcinoma (HepG2) cells. Epigenetics. 16:79–91. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Shulman Z and Stern-Ginossar N: The RNA
modification N6-methyladenosine as a novel regulator of the immune
system. Nat Immunol. 21:501–512. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Cheng W, Li M, Zhang L, Zhou C, Yu S, Peng
X and Zhang W and Zhang W: New roles of N6-methyladenosine
methylation system regulating the occurrence of non-alcoholic fatty
liver disease with N6-methyladenosine-modified MYC. Front.
Pharmacol. 13:9731162022.PubMed/NCBI
|
|
82
|
Jin S, Li M, Chang H, Wang R, Zhang Z,
Zhang J, He Y and Ma H: The m6A demethylase ALKBH5 promotes tumor
progression by inhibiting RIG-I expression and interferon alpha
production through the IKKε/TBK1/IRF3 pathway in head and neck
squamous cell carcinoma. Mol Cancer. 21:972022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ye G, Li J, Yu W, Xie Z, Zheng G, Liu W,
Wang S, Cao Q, Lin J, Su Z, et al: ALKBH5 facilitates CYP1B1 mRNA
degradation via m6A demethylation to alleviate MSC senescence and
osteoarthritis progression. Exp Mol Med. 55:1743–1756. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Fu Y and Zhuang X: m(6)A-binding YTHDF
proteins promote stress granule formation. Nat Chem Biol.
16:955–963. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Khan D, Ramachandiran I, Vasu K, China A,
Khan K, Cumbo F, Halawani D, Terenzi F, Zin I, Long B, et al:
Homozygous EPRS1 missense variant causing hypomyelinating
leukodystrophy-15 alters variant-distal mRNA m(6)A site
accessibility. Nat Commun. 15:42842024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sun R, Tian X, Li Y, Zhao Y, Wang Z, Hu Y,
Zhang L, Wang Y, Gao D, Zheng S and Yao J: The m6A reader
YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox
Biol. 54:1023782022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Alarcón CR, Goodarzi H, Lee H, Liu X,
Tavazoie S and Tavazoie SF: HNRNPA2B1 is a mediator of
m(6)A-dependent nuclear RNA processing events. Cell. 162:1299–1308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Jiang L, Lin W, Zhang C, Ash PEA, Verma M,
Kwan J, van Vliet E, Yang Z, Cruz AL, Boudeau S, et al: Interaction
of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the
progression of tauopathy. Mol Cell. 81:4209–4227.e12. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang L, Wen M and Cao X: Nuclear hnRNPA2B1
initiates and amplifies the innate immune response to DNA viruses.
Science. 365:eaav07582019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Miller C, Ealy A, Gregory A, Janarthanam
C, Albers W, Richardson G, Jin H, Zenitsky G, Anantharam V,
Kanthasamy A and Kanthasamy AG: Pathological α-synuclein
dysregulates epitranscriptomic writer METTL3 to drive
neuroinflammation in microglia. Cell Rep. 44:1156182025. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang T, Zhang SW, Zhang SY and Ma QQ:
m(6)Aexpress-Reader: Prediction of m(6)A regulated expression genes
by integrating m(6)A sites and reader binding information in
specific-context. Methods. 203:167–178. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Boriack-Sjodin PA, Ribich S and Copeland
RA: RNA-modifying proteins as anticancer drug targets. Nat Rev Drug
Discov. 17:435–453. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wei J, Harada BT, Lu D, Ma R, Gao B, Xu Y,
Montauti E, Mani N, Chaudhuri SM, Gregory S, et al: HRD1-mediated
METTL14 degradation regulates m(6)A mRNA modification to suppress
ER proteotoxic liver disease. Mol Cell. 81:5052–5065.e6. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chai J, Wang Q, Qiu Q, Han G, Chen Y, Li W
and Zhang H: YBX1 regulates the survival of chronic myeloid
leukemia stem cells by modulating m(6)A-mediated YWHAZ stability.
Cell Oncol (Dordr.). 46:451–464. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Evans MK, Matsui Y, Xu B, Willis C, Loome
J, Milburn L, Fan Y, Pagala V and Peng JC: Ybx1 fine-tunes PRC2
activities to control embryonic brain development. Nat Commun.
11:40602020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Jiang WJ, Sun MH, Li XH, Lee SH, Heo G,
Zhou D and Cui XS: Y-box binding protein 1 influences zygotic
genome activation by regulating N6-methyladenosine in porcine
embryos. J Cell Physiol. 238:1592–1604. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Peng J, He J, Lin L, Li Y and Xia Y:
Neural stem cell extracellular vesicles carrying YBX1 inhibited
neuronal pyroptosis through increasing m6A-modified GPR30 stability
and expression in ischemic stroke. Transl Stroke Res. 16:262–279.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Huang H, Weng H, Sun W, Qin X, Shi H, Wu
H, Zhao BS, Mesquita A, Liu C, Yuan CL, et al: Recognition of RNA
N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and
translation. Nat Cell Biol. 20:285–295. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ramesh-Kumar D and Guil S: The IGF2BP
family of RNA binding proteins links epitranscriptomics to cancer.
Semin Cancer Biol 86(Pt 3). 18–31. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ying Y, Wu Y, Zhang F, Tang Y, Yi J, Ma X,
Li J, Chen D, Wang X, Liu X, et al: Co-transcriptional
R-loops-mediated epigenetic regulation drives growth retardation
and docetaxel chemosensitivity enhancement in advanced prostate
cancer. Mol Cancer. 23:792024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Li W, Li W, Leng Y, Xu H, Xia Z and Wang
Y: ALKBH5-Mediated M(6)A demethylation of G3BP1 attenuates
ferroptosis via cytoplasmic retention of YBX1/p53 in diabetic
myocardial ischemia-reperfusion injury. Adv Sci (Weinh).
12:e072542025. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang C, Shen S, Kang J, Sugai-Munson A,
Xiao X, Zhang Y, Zhu J, Liu Z, McKay TB, Akeju O, et al: METTL3 is
essential for exercise benefits in diabetic cardiomyopathy.
Circulation. 152:327–345. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Xi Q, Yang G, He X, Zhuang H, Li L, Lin B,
Wang L, Wang X, Fang C, Chen Q, et al: M(6)A-mediated upregulation
of lncRNA TUG1 in liver cancer cells regulates the antitumor
response of CD8(+) T cells and phagocytosis of macrophages. Adv Sci
(Weinh). 11:e24006952024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yin H, Chen L, Piao S, Wang Y, Li Z, Lin
Y, Tang X, Zhang H, Zhang H and Wang X: M6A RNA
methylation-mediated RMRP stability renders proliferation and
progression of non-small cell lung cancer through regulating
TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ. 30:605–617. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Zhang H, Han Y, Wu C, Wang S, Chen M, Xu
Q, Wei H, Zhou X and Wang G: m6A-modified LINC02418 induces
transcriptional and post-transcriptional modification of CTNNB1 via
interacting with YBX1 and IGF2BP1 in colorectal cancer. Cell Death
Discov. 11:1012025. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Gunasekaran VP, Nishi K, Sivakumar D,
Sivaraman T and Mathan G: Identification of
2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor
to Y box binding protein-1 (YB-1) and its therapeutic actions
against breast cancer. Eur J Pharm Sci. 116:2–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
He M, Li T, Wang A, Liu Y, Wang X, Liu Z,
Xie J, Wang Y, Wang Y, Ren Z, et al: MARCH8/NSUN6/ROS-mediated DNA
damage positive feedback loop regulates cisplatin resistance in
osteosarcoma. Cell Death Differ. Jul 19–2025.(Epub ahead of print).
View Article : Google Scholar
|
|
108
|
Huang H, Fang L, Zhu C, Lv J, Xu P, Chen
Z, Zhang Z, Wang J, Wang W and Xu Z: YBX1 promotes 5-Fluorouracil
resistance in gastric cancer via m5C-dependent ATG9A mRNA
stabilization through autophagy. Oncogene. 44:2357–2371. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Li D, Chu X, Liu W, Ma Y, Tian X and Yang
Y: The regulatory roles of RNA-binding proteins in the tumour
immune microenvironment of gastrointestinal malignancies. RNA Biol.
22:1–14. 2025. View Article : Google Scholar
|
|
110
|
Ma L, Singh J and Schekman R: Two
RNA-binding proteins mediate the sorting of miR223 from
mitochondria into exosomes. Elife. 12:e858782023. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Dinh NTM, Nguyen TM, Park MK and Lee CH:
Y-Box binding protein 1: Unraveling the multifaceted role in cancer
development and therapeutic potential. Int J Mol Sci. 25:7172024.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Alkrekshi A, Wang W, Rana PS, Markovic V
and Sossey-Alaoui K: A comprehensive review of the functions of
YB-1 in cancer stemness, metastasis and drug resistance. Cell
Signal. 85:1100732021. View Article : Google Scholar : PubMed/NCBI
|
